...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >In vitro interactions of antimicrobial combinations with fosfomycin against KPC-2-producing Klebsiella pneumoniae and protection of resistance development.
【24h】

In vitro interactions of antimicrobial combinations with fosfomycin against KPC-2-producing Klebsiella pneumoniae and protection of resistance development.

机译:抗菌药物与磷霉素在体外对产生KPC-2的肺炎克雷伯菌的相互作用以及对耐药性的保护作用。

获取原文
获取原文并翻译 | 示例

摘要

Using time-kill methodology, we investigated the interactions of fosfomycin with meropenem or colistin or gentamicin against 17 genetically distinct Klebsiella pneumoniae clinical isolates carrying blaKPC-2. Synergy was observed with meropenem or colistin against 64.7 and 11.8% of tested isolates, while the combination with gentamicin resulted in indifference. All studied combinations showed improved bactericidal activity, compared to fosfomycin alone and prevented the development of fosfomycin resistance in 69.2, 53.8, and 81.8% of susceptible isolates, respectively.
机译:使用时间杀灭方法,我们调查了磷霉素与美罗培南或大肠菌素或庆大霉素对17种携带blaKPC-2的遗传上不同的肺炎克雷伯菌的临床分离株的相互作用。美罗培南或大肠菌素对64.7%和11.8%的测试菌株具有协同作用,而与庆大霉素的组合则无差异。与单独的磷霉素相比,所有研究的组合均显示出改善的杀菌活性,并分别在易感菌株中阻止了磷霉素耐药性的发展,分别为69.2、53.8和81.8%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号